NOVARTIS AG CEDEAR EACH 4 REP 1 revenue breakdown overview

NOVARTIS AG CEDEAR EACH 4 REP 1 revenue for the last year amounted to 51.87 T ARS, the most of which — 14.74 T ARS — came from its highest performing source at the moment, Oncology, the year earlier bringing 11.73 T ARS. The greatest contribution to the revenue figure was made by United States — last year it brought NOVARTIS AG CEDEAR EACH 4 REP 1 21.14 T ARS, and the year before that — 15.50 T ARS.